Tissue and Blood‐Based Tumor Mutational Burden Predicts Treatment Response to PD ‐1 Blockade in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis

Documenti analoghi

• A Comprehensive Immune Checkpoint Phenotype Predicts Response and Survival to PD ‐1 Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
  di: Mathias Fiedler, et al.
  Pubblicazione: (2026)
• Aberrant Splicing Burden Predicts Immune Infiltration and Prognosis in Head and Neck Squamous Cell Carcinomas
  di: Sandhya Kalavacherla, et al.
  Pubblicazione: (2025)
• Impact of Extranodal Extension in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Systematic Review and Meta‐Analysis
  di: Andrea Costantino, et al.
  Pubblicazione: (2025)
• Differences in PD‐L1, PD‐L2, and EGFR Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective Study
  di: Ryosuke Sato, et al.
  Pubblicazione: (2025)
• Impact of Prior Neck Treatment Status on Salvage Treatment Outcomes in Isolated Regional Recurrence of Head and Neck Squamous Cell Carcinoma
  di: Younghac Kim, et al.
  Pubblicazione: (2025)